JPRN-UMIN000028605已完成未知
A retrospective study for ALK positive Lung Cancer - The Clinical Benefits of Sequential Therapy using Crizotinib followed by Alectinib in Clinical Practice: A Multicenter Retrospective Study. - (WJOG9516L) - A retrospective study for ALK positive Lung Cancer
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •No prior exposure of ceritinib before crizotinib or alectinib, regardless of clinical trial or practice.
研究者
相似试验
已完成
Unknown
A retrospective analysis on the lung cancer specimens for Oncomine Dx Target Test in Keio University Hospitalon-small cell lung cancer (NSCLC)JPRN-UMIN000050424Keio University School of Medicine500
已完成
不适用
Clinical study on the treatment of lung cancer related fatigue with deficiency of Qi-blood by traditional Chinese herb medicine combined with AcupunctureITMCTR2000003964Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
招募中
不适用
trecht COhort for Lung cancer Outcome Reporting and trial inclusion (U-COLOR)10038666Lung cancerNL-OMON54999niversitair Medisch Centrum Utrecht3,200
已完成
不适用
tritional Assessment in Non-small Cell lung cancer patientslungcancerNon Small Cell Lung Cancer10038666NL-OMON50451Antoni van Leeuwenhoek Ziekenhuis100
已完成
不适用
Treatment of lung cancer - a health care research study using data cancer registry data (registration according to § 65c SGB V)C34Malignant neoplasm of bronchus and lungDRKS00025080niversität zu Lübeck, Institut für Sozialmedizin und Epidemiologie70,804